![](/img/cover-not-exists.png)
Efficacy and safety of polyethylene glycol loxenatide ( PEX168 ) monotherapy in type 2 diabetes patients: a multicenter, randomized, doubleâblind, placeboâcontrolled, phase 3a clinical trial
Shuai, Ying, Yang, Gangyi, Zhang, Qiu, Li, Wei, Luo, Yong, Ma, Jianhua, Chen, Daoxiong, Yang, Jialin, Wang, Xinjun, Hu, Ji, Xu, Ning, Yang, WenyingJournal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.14198
Date:
September, 2020
File:
PDF, 666 KB
2020